Skip to content

Sequential Bilateral Accelerated Theta Burst Stimulation for Rumination in Depression: A Randomized Controlled Trial

Sequential Bilateral Accelerated TBS for Rumination in Depression: A Randomized Controlled Trial with fMRI Investigation of Neural Mechanisms

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121225
Enrollment
Unknown
Registered
2026-03-26
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

Accelerated Bilateral TBS Group:Using Yiruide magnetic stimulator with figure-8 coil, Beam F3 targeting method. Three times daily for 10 consecutive days (total 30 sessions). Parameters: left DLPFC re
right DLPFC received cTBS (1200 pulses, ~80 seconds), 30-minute interval between treatments. Intensity at 120% RMT (or 80–120% AMT).
Sham Control Group:Sham stimulation (reduced intensity threshold, coil positioned at 90 degrees, or emitting similar sounds and vibrations without effective stimulation), three times daily for 10 cons

Sponsors

Zigong Mental Health Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
13 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for Major Depressive Disorder (MDD) according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5); 2. Aged between 13 and 55 years, right-handed; 3. Total score of the Ruminative Responses Scale (RRS) > 50, indicating significant rumination symptoms; 4. Volunteer to participate and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. A history of epilepsy or severe organic brain disease; 2. Presence of metallic implants in the body (e.g., cardiac pacemaker, deep brain stimulation electrodes); 3. Comorbid bipolar disorder, schizophrenia, or other psychotic disorders; 4. Presence of severe and unstable physical or neurological diseases; 5. Received electroconvulsive therapy (ECT) within the past 3 months; 6. Conditions unsuitable for MRI scanning, such as ferromagnetic metal implants or claustrophobia.

Design outcomes

Primary

MeasureTime frame
Reduction rate of the Ruminative Response Scale (RRS) score. ;

Secondary

MeasureTime frame
Reduction rate of the 17-item Hamilton Depression Rating Scale (HAMD-17) score.;Reduction rate of the Montgomery-?sberg Depression Rating Scale (MADRS) score.;Reduction rate of the Generalized Anxiety Disorder 7-item scale (GAD-7) score.;Reduction rate of the Columbia-Suicide Severity Rating Scale (C-SSRS) score.;fMRI brain imaging metrics.;

Countries

China

Contacts

Public ContactTan Youguo

Zigong Mental Health Center

13890055456@163.com+86 138 9005 5456

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 4, 2026